Cumberland Pharmaceuticals, Inc. (CPIX)
6.62
-0.17
(-2.50%)
USD |
NASDAQ |
Sep 08, 16:00
6.80
+0.18
(+2.72%)
Pre-Market: 08:37
Cumberland Pharmaceuticals Shareholders Equity (Quarterly) : 17.44M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 17.44M |
| March 31, 2026 | 21.64M |
| December 31, 2025 | 24.88M |
| September 30, 2025 | 26.12M |
| June 30, 2025 | 27.99M |
| March 31, 2025 | 28.66M |
| December 31, 2024 | 22.85M |
| September 30, 2024 | 24.78M |
| June 30, 2024 | 26.35M |
| March 31, 2024 | 27.49M |
| December 31, 2023 | 29.60M |
| September 30, 2023 | 35.99M |
| June 30, 2023 | 37.16M |
| March 31, 2023 | 36.36M |
| December 31, 2022 | 36.27M |
| September 30, 2022 | 38.76M |
| June 30, 2022 | 39.46M |
| March 31, 2022 | 41.02M |
| December 31, 2021 | 42.81M |
| September 30, 2021 | 46.82M |
| June 30, 2021 | 47.95M |
| March 31, 2021 | 47.02M |
| December 31, 2020 | 46.99M |
| September 30, 2020 | 47.93M |
| June 30, 2020 | 48.48M |
| Date | Value |
|---|---|
| March 31, 2020 | 49.89M |
| December 31, 2019 | 51.12M |
| September 30, 2019 | 51.73M |
| June 30, 2019 | 54.06M |
| March 31, 2019 | 55.43M |
| December 31, 2018 | 55.84M |
| September 30, 2018 | 58.20M |
| June 30, 2018 | 59.91M |
| March 31, 2018 | 61.09M |
| December 31, 2017 | 64.12M |
| September 30, 2017 | 65.10M |
| June 30, 2017 | 66.66M |
| March 31, 2017 | 72.36M |
| December 31, 2016 | 73.25M |
| September 30, 2016 | 74.53M |
| June 30, 2016 | 74.47M |
| March 31, 2016 | 75.40M |
| December 31, 2015 | 76.89M |
| September 30, 2015 | 77.59M |
| June 30, 2015 | 78.74M |
| March 31, 2015 | 79.37M |
| December 31, 2014 | 80.76M |
| September 30, 2014 | 81.10M |
| June 30, 2014 | 80.93M |
| March 31, 2014 | 79.15M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 62.88M |
| Total Liabilities (Quarterly) | 45.77M |
| Debt to Equity Ratio | 0.2703 |
| Current Ratio | 0.9559 |
| Net Debt Paydown Yield | 1.18% |